Public Profile

SPI Pharma, Inc.

SPI Pharma, Inc., a leading player in the pharmaceutical industry, is headquartered in the United States and operates across various global regions. Founded in 1946, the company has established itself as a trusted provider of innovative solutions in the development and manufacturing of pharmaceutical excipients and active pharmaceutical ingredients (APIs). SPI Pharma is renowned for its core products, including its proprietary formulations and delivery systems, which enhance drug efficacy and patient compliance. The company’s commitment to quality and innovation has positioned it as a preferred partner for pharmaceutical manufacturers worldwide. With a strong focus on research and development, SPI Pharma continues to achieve significant milestones, solidifying its reputation as a key contributor to the advancement of pharmaceutical technologies.

DitchCarbon Score

How does SPI Pharma, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

27

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

SPI Pharma, Inc.'s score of 27 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

0%

Let us know if this data was useful to you

SPI Pharma, Inc.'s reported carbon emissions

SPI Pharma, Inc., headquartered in the US, currently does not have available carbon emissions data for recent years, as no specific emissions figures have been provided. Consequently, there are no documented reduction targets or climate commitments outlined by the company. In the absence of concrete data, it is essential to note that many companies in the pharmaceutical industry are increasingly focusing on sustainability and reducing their carbon footprints. SPI Pharma may be engaging in similar initiatives, but specific details regarding their climate commitments or emissions reduction strategies are not available at this time.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. SPI Pharma, Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for SPI Pharma, Inc. is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

SPI Pharma, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Icl Performance Products LP

US
Chemicals nec
Updated 3 months ago
DitchCarbon Score

Summit Holding Southeast, Inc.

US
Insurance and pension funding services, except compulsory social security services (66)
Updated 3 months ago
DitchCarbon Score

Reheis, Inc.

US
Updated 3 months ago
DitchCarbon Score

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers